American Trust’s Idexx Laboratories IDXX Stock Holding History

American Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$688K	Sell	1,307 -165	-11%	-$92.5K	0.05%	139
2026 Q1	$827K	Sell	1,472 -413	-22%	-$265K	0.07%	121
2025 Q4	$1.28M	Sell	1,885 -55	-3%	-$37.5K	0.11%	103
2025 Q3	$1.24M	Buy	1,940 +284	+17%	+$172K	0.1%	106
2025 Q2	$888K	Buy	1,656 +264	+19%	+$126K	0.08%	120
2025 Q1	$585K	Buy	1,392 +2	+0.1%	+$868	0.14%	88
2024 Q4	$575K	Sell	1,390 -109	-7%	-$47.8K	0.04%	161
2024 Q3	$757K	Buy	+1,499	New	+$728K	0.06%	112
2023 Q3	–	Sell	-431	Closed	-$216K	–	345
2023 Q2	$216K	Buy	431 +21	+5%	+$10.1K	0.02%	381
2023 Q1	$205K	Buy	+410	New	+$196K	0.01%	413
2022 Q1	–	Sell	-372	Closed	-$245K	–	517
2021 Q4	$245K	Buy	+372	New	+$234K	0.02%	288

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

American Trust's IDXX Position: Q2 2026 in Review

American Trust reduced its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, selling an estimated $92.5K and leaving 1,307 shares worth $688K. The position accounts for 0.05% of the portfolio, ranked #139.

American Trust first reported a position in IDXX in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.28M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

American Trust held 1,307 shares of Idexx Laboratories worth $688K as of Q2 2026.
American Trust sold 165 Idexx Laboratories shares in Q2 2026, an estimated $92.5K.
Idexx Laboratories made up 0.05% of American Trust's portfolio in Q2 2026, its #139 holding.
American Trust first reported a position in Idexx Laboratories in Q4 2021 and has held it in 11 quarters since.
American Trust's Idexx Laboratories position peaked at $1.28M in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on American Trust's 13F filing for Q2 2026, filed 14 Aug 2026.